Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
1.
J Eur Acad Dermatol Venereol ; 34(11): 2620-2629, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32474947

ABSTRACT

BACKGROUND: Acral chilblain-like lesions are being increasingly reported during COVID-19 pandemic. However, only few patients proved positivity for SARS-CoV-2 infection. The relationship between this skin manifestation and COVID-19 infection has not been clarified yet. OBJECTIVE: To thoroughly characterize a prospective group of patients with chilblain-like lesions and to investigate the possible relationship with SARS-CoV-2 infection. METHODS: Following informed consent, patients underwent (i) clinical evaluation, (ii) RT-PCR and serology testing for SARS-CoV-2, (iii) digital videocapillaroscopy of finger and toe nailfolds, (iv) blood testing to screen for autoimmune diseases and coagulation anomalies, and (v) skin biopsy for histopathology, direct immunofluorescence and, in selected cases, electron microscopy. RESULTS: Nineteen patients, all adolescents (mean age: 14Ā years), were recruited. 11/19 (58%) of them and/or their cohabitants reported flu-like symptoms one to two months prior to skin manifestation onset. Lesions were localized to toes and also heels and soles. Videocapillaroscopy showed pericapillary oedema, dilated and abnormal capillaries, and microhaemorrhages both in finger and toe in the majority of patients. Major pathological findings included epidermal basal layer vacuolation, papillary dermis oedema and erythrocyte extravasation, perivascular and perieccrine dermal lymphocytic infiltrate, and mucin deposition in the dermis and hypodermis; dermal vessel thrombi were observed in two cases. Blood examinations were normal. Nasopharyngeal swab for SARS-CoV-2 and IgG serology for SARS-CoV-2 nucleocapsid protein were negative. Importantly, IgA serology for S1 domain of SARS-CoV-2 spike protein was positive in 6 patients and borderline in 3. CONCLUSIONS: Chilblain-like lesions during COVID-19 pandemic have specific epidemiologic, clinical, capillaroscopic and histopathological characteristics, which distinguish them from idiopathic perniosis. Though we could not formally prove SARS-CoV-2 infection in our patients, history data and the detection of anti-SARS-COV-2 IgA strongly suggest a relationship between skin lesions and COVID-19. Further investigations on the mechanisms of SARS-CoV-2 infection in children and pathogenesis of chilblain-like lesions are warranted.


Subject(s)
COVID-19/complications , Chilblains/virology , Adolescent , Biopsy , COVID-19/epidemiology , COVID-19 Testing , Female , Humans , Italy/epidemiology , Male , Pandemics , Prospective Studies , SARS-CoV-2
2.
Foods ; 12(11)2023 May 29.
Article in English | MEDLINE | ID: mdl-37297428

ABSTRACT

According to the United Nations, approximately one-third of the food produced for human consumption is wasted. The actual linear "Take-Make-Dispose" model is nowadays obsolete and uneconomical for societies and the environment, while circular thinking in production systems and its effective adoption offers new opportunities and benefits. Following the "Waste Framework Directive" (2008/98/CE), the European Green Deal, and the actual Circular Economy Action Plan, when prevention is not possible, recovering an unavoidable food waste as a by-product represents a most promising pathway. Using last year's by-products, which are rich in nutrients and bioactive compounds, such as dietary fiber, polyphenols, and peptides, offer a wake-up call to the nutraceutical and cosmetic industry to invest and develop value-added products generated from food waste ingredients.

3.
Int J Immunopathol Pharmacol ; 24(2 Suppl): 95-101, 2011.
Article in English | MEDLINE | ID: mdl-21781453

ABSTRACT

Oncogenic HPVs are necessarily involved in cervical cancer but their role in oral carcinogenesis is debated. To detect HPV in oral cancer, 38 cases of formalin fixed-paraffin embedded OSCC were studied by both DNA genotyping (MY09/11 L1 consensus primers in combination with GP5-GP6 primer pair followed by sequencing) and immunohistochemistry (monoclonal Abs against capsid protein and HPV-E7 protein, K1H8 DAKO and clone 8C9 INVITROGEN, respectively). HPV-16 tonsil cancer was used as positive control. The overall prevalence of HPV infection in OSCCs was 10.5%. Amplification of DNA samples showed single HPV DNA infection in 3 cases (HPV16; HPV53; HPV70) and double infection in one case of cheek cancer (HPV31/HPV44). The overall HR-HPV prevalence was 7.5%. E-7 antigen was immunohistochemically detected in all HPV-positive cases. HPV+ OSCC cases showed an overall better outcome than HPV negative oral cancers, as evaluated by Kaplan-Meier curves. HPVs exert their oncogenic role after DNA integration, gene expression of E5, E6 and E7 loci and p53/pRb host proteins suppression. This study showed that HPV-E7 protein inactivating pRb is expressed in oral cancer cells infected by oncogenic HPV other than classical HR-HPV-16/18. Interestingly HPV-70, considered a low risk virus with no definite collocation in oncogenic type category, gives rise to the expression of HPV-E7 protein and inactivate pRb in oral cancer. HPV-70, as proved in current literature, is able to inactivates also p53 protein, promoting cell immortalization. HPV-53, classified as a possible high risk virus, expresses E7 protein in OSCC, contributing to oral carcinogenesis. We have identified among OSCCs, a subgroup characterized by HPV infection (10.5%). Finally, we have proved the oncogenic potential of some HPV virus types, not well known in literature.


Subject(s)
Carcinoma, Squamous Cell/virology , Mouth Neoplasms/virology , Papillomaviridae/genetics , Papillomavirus Infections/virology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , DNA, Viral/analysis , Female , Humans , Male , Middle Aged , Mouth Neoplasms/epidemiology , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , Neoplasm Staging , Papillomaviridae/metabolism , Papillomavirus E7 Proteins/genetics , Papillomavirus E7 Proteins/metabolism , Papillomavirus Infections/epidemiology , Papillomavirus Infections/genetics
4.
Int J Pharm ; 353(1-2): 124-30, 2008 Apr 02.
Article in English | MEDLINE | ID: mdl-18162344

ABSTRACT

Lipid microparticles, containing 30% and 50% (w/w) propafenone hydrochloride as the active molecule and cetearyl alcohol and Pluronic F68 as excipients, were prepared by Hot Air Coating (HAC). The aim of the work was to identify the kinetics and the mechanism of the drug release process from these microparticulate systems. The application of the Weibull model to the release data from each single fraction of microparticles suggests that a diffusive mechanism governs drug release from microparticles. Thus, we proposed and applied a release kinetic model to the experimental data that takes into account the diffusion as the predominantly mechanism of drug release. The model proposed is a modified version of the exponential equation in which the product of the apparent release rate constant K, specific for each drug/excipient mixture, and the area-to-volume ratio of particles was used. The K values of single fractions of HAC microparticles (coded K(fr)) are very similar to those of the mixtures of particles obtained from the process (coded K(pool)). Using the K(pool) constants, the release behaviour of ensembles of different size microparticles of well-known composition was predicted. The strength of the model was proved by the good fitting of the experimental release data versus those predicted (R(2)> or =0.997).


Subject(s)
Propafenone/chemistry , Technology, Pharmaceutical , Kinetics , Models, Theoretical , Propafenone/administration & dosage , Solubility
5.
Clin Exp Rheumatol ; 25(2): 268-74, 2007.
Article in English | MEDLINE | ID: mdl-17543152

ABSTRACT

OBJECTIVE: Prothrombin (PT) is a target for antibodies with lupus anticoagulant (LA) activity, suggesting the possible application of anti-prothrombin antibody (aPT) assays in patients with antiphospholipid syndrome (APS). Different methods - both homemade and commercial - for the detection of aPT are available, but they seem to produce conflicting results. The purpose of this study was to compare the performance of different assays on a set of well-characterized serum samples. PATIENTS AND METHODS: Sera were gathered from 4 FIRMA institutions, and distributed to 15 participating centres. Forty-five samples were from patients positive for LA and/or anticardiolipin antibodies (aCL) with or without APS, and 15 were from rheumatoid arthritis (RA) patients negative for antiphospholipid antibodies. The samples were evaluated for IgG and IgM antibodies using a homemade direct aPT assay (method 1), a homemade phosphatidylserine-dependent aPT assay (aPS/PT, method 2), and two different commercial kits (methods 3 and 4). In addition, a commercial kit for the detection of IgG-A-M aPT (method 5) was used. RESULTS: Inter-laboratory results for the 5 methods were not always comparable when different methods were used. Good inter-assay concordance was found for IgG antibodies evaluated using methods 1, 3, and 4 (Cohen k > 0.4), while the IgM results were discordant between assays. In patients with thrombosis and pregnancy losses, method 5 performed better than the others. CONCLUSION: While aPT and aPS/PT assays could be of interest from a clinical perspective, their routine performance cannot yet be recommended because of problems connected with the reproducibility and interpretation of the results.


Subject(s)
Antibodies, Anti-Idiotypic/blood , Antiphospholipid Syndrome/immunology , Arthritis, Rheumatoid/immunology , Enzyme-Linked Immunosorbent Assay/methods , Prothrombin/immunology , Antiphospholipid Syndrome/blood , Arthritis, Rheumatoid/blood , Female , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Lupus Coagulation Inhibitor/immunology , Reproducibility of Results
6.
Water Sci Technol ; 56(3): 39-48, 2007.
Article in English | MEDLINE | ID: mdl-17802836

ABSTRACT

This paper describes a two-year performance evaluation of four different constructed wetland (CW) treatment systems designed by IRIDRA Srl, located in central Italy. All four CW systems were established to treat wastewater effluent from different tourist activities: (1) one single-stage CW for secondary treatment of domestic wastewater (30 p.e.) at a holiday farm site; (2) a hybrid compact system consisting of two stages, a horizontal flow (HF) system followed by a vertical flow (VF) system for the secondary treatment of effluent from a 140 p.e. tourist resort; (3) a single-stage vertical flow (VF) CW for a 100 p.e. mountain shelter; and (4) a pair of single-stage, HF CWs for the secondary treatment of segregated grey and black water produced by an 80 p.e. camping site. These tourism facilities are located in remote areas and share some common characteristics concerning their water management: they have high variability of water consumption and wastewater flow, depending on the season, weather and weekly regularities; they have no connection to a public sewer and most sites are located in a sensitive environment. Total suspended solids (TSS), chemical oxygen demand (COD), biochemical oxygen demand (BOD5), ammonium (N-NH4+), nitrate (N-NOx), total nitrogen (Ntot), total phosphorus (Ptot), total coliform (TC), faecal coliform (FC), E. coli removal efficiencies for all four CW systems are presented. The results from this study demonstrate the potential of CWs as a suitable technology for treating wastewater from tourism facilities in remote areas. A very efficient COD reduction (83-95%) and pathogen elimination (3-5 logs) have been achieved. Furthermore, the CWs are easily maintained, robust (not sensitive to peak flows), constructed with local materials, and operate with relatively low cost.


Subject(s)
Waste Disposal, Fluid/methods , Water Purification/methods , Wetlands , Environment Design , Italy , Waste Disposal, Fluid/standards , Water Purification/standards
7.
Oral Oncol ; 42(6): 638-45, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16483833

ABSTRACT

We aimed to evaluate if in oral squamous cell carcinoma (OSCC) there is a relationship between histological grading (HG), TNM clinical stage and HPV infection; and to study the performance of fuzzy logic compared to traditional statistics, in the analysis of HPV status and correlates of OSCC. In cross-sectional analysis, the study group comprised 63 patients (mean age 68.89 years (SD +/-11.78), range (32-93); males 28 (44.4%), females 35 (55.6%)) with OSCC histologically diagnosed. HPV-DNA was studied in exfoliated oral epithelial cells by nested PCR (MY09/MY11 and GP5+/GP6+ primers). Data were analysed in parallel by traditional statistics with multivariate analysis and a fuzzy logic (FL) technique (membership functions as input, the ANFIS methodology, and the Sugeno's model of first order). HPV infection was detected in 24/63 (38.1%) of OSCC, as being HPV+ve 14/36 (38.9%) in G1, 7/18 (38.9%) in G2, and 3/9 (33.3%) in G3; HPV+ve 8/33 (24.2%) in Stage I, 9/12 (75.0%) in Stage II, 6/11(54.5%) in Stage III, and 1/7 (14.3%) in Stage IV. In both methods of analysis, no significantly increased risk of HPV infection was found for any HG score; whereas, TNM stage II was significantly associated to HPV infection (p=0.004; OR=9.375 (95% CI=2.030:43.30); OR'=11.148 (95% CI=1.951:43.30)), and, in particular, to primary tumour size T2 (p=0.0036; OR=7.812 (95% CI=1.914:31.890); OR'=9.414 (95% CI=1.846:48.013)); FL (% of prevision: 79.8; Root Mean-Square Error (RMSE): 0.29). No association was found between HPV infection and any demographical variable. Our findings show an association between HPV infection with TNM (stage II-T2), but not with histological grading of OSCC. Also, FL seems to be an additional effective tool in analysing the relationship of HPV infection with correlates of OSCC.


Subject(s)
Carcinoma, Squamous Cell/epidemiology , Mouth Neoplasms/epidemiology , Papillomavirus Infections/epidemiology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/virology , Cross-Sectional Studies , Female , Fuzzy Logic , Humans , Male , Middle Aged , Models, Biological , Mouth Neoplasms/pathology , Mouth Neoplasms/virology , Multivariate Analysis , Papillomavirus Infections/pathology
8.
J Exp Clin Cancer Res ; 25(3): 297-302, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17167967

ABSTRACT

The clinical importance of Barrett's esophagus is related to its correlation to adenocarcinoma. The diagnosis is based on histologic demonstration of specialized intestinal metaplasia in the distal esophagus. The aim of this study was to assess the prevalence of intestinal metaplasia of the distal esophagus in a population submitted to gastroscopy not selected for reflux disease, and with columnar lined distal esophagus between 0.5 and 2 cm. Four biopsies in the distal esophagus were done in 224 patients undergoing routine gastroscopy. Patients were not selected for gastroesophageal reflux. Other clinical parameters were recorded to assess any possible association. In four Centers 224 patients received endoscopy with biopsies demonstrating specialized intestinal metaplasia in 21% of cases. No association was present among the patients with esophagitis or hiatal hernia, as well as with reflux symptoms. A significant association was present in over 70 (females), as well as with the presence of antral intestinal metaplasia demonstrated in 45 patients by gastric biopsies. No other significant associations were present. Biopsy samplings can diagnose the presence of intestinal metaplasia during endoscopy in patients endoscopically suspected for Barrett's esophagus: at present there is not clear evidence to promote this screening to achieve mortality reduction of esophageal adenocarcinoma.


Subject(s)
Barrett Esophagus/diagnosis , Endoscopy, Gastrointestinal , Esophagus/pathology , Intestinal Mucosa/pathology , Aged , Aged, 80 and over , Female , Humans , Male , Metaplasia/epidemiology , Middle Aged , Prevalence
9.
Int J Pharm ; 293(1-2): 225-34, 2005 Apr 11.
Article in English | MEDLINE | ID: mdl-15778060

ABSTRACT

In the present work, the Hot Air Coating (HAC) technique was used to prepare microparticulate systems containing nifedipine. Binary mixtures constituting of nifedipine and cetearyl alcohol (CA) in different proportions (30:70, 50:50, 70:30) were studied: they were homogenized by mixing or milling before spray treatment and successively subjected to a coating procedure with the HAC apparatus fed with air at 120 degrees C under a pressure of 4.5 atm. Morphology, entrapment efficiency, drug stability, thermal behaviour and the drug dissolution profile of HAC-treated and non-treated materials were examined and compared. The HAC products show the possession of physical and physico-chemical properties and dissolution behaviour different from those of the initial physical mixtures. The operative conditions employed in the spray process allow the obtaining of microparticles containing relevant percentages of the drug (at least up to 50%). Moreover, the experimental results give evidence that the milling pre-treatment of mixtures, unlike mixing, has significant effects on the properties of the lipid-coated microparticles.


Subject(s)
Microspheres , Nifedipine/chemical synthesis , Technology, Pharmaceutical/methods , Hot Temperature , Nifedipine/analysis , Tablets, Enteric-Coated
10.
Eur Rev Med Pharmacol Sci ; 19(21): 4153-63, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26592842

ABSTRACT

OBJECTIVE: Although human papillomavirus (HPV) infection has been studied extensively in women, data on male infection are limited. The purpose of this study was to investigate persistence of HPV infection at multiple genital sites in men and to define potential associations with socio-behavioural characteristics. PATIENTS AND METHODS: Penile, urethral and seminal specimens were tested by the INNO-LiPA HPV system (Innogenetics) and a PCR assay. Persistence was defined as the detection of same HPV type at ≥ 2 consecutive visits. The Kaplan-Meier method and the log-rank test were applied to estimate the likelihood of persistence. RESULTS: A total of 50 men (median age: 33 years) were followed for a median of 14.7 months. Altogether, 49%, 36%, 26% and 11% of baseline HPV-positive men had 6-, 12-, 18- and 24-month persistent infection with any HPV type, respectively. The 6-, 12- and 18- month persistence was more common for oncogenic HPV infections; 24-month persistence was similar. The median duration of persistence was 21.7 months for any HPV. The median duration of persistence for any HPV type was significantly longer in the penile sample (22.5 months, 95% CI: 18.3-26.7) than the semen sample (15.3 months, 95% CI: 14.5-16.1). CONCLUSIONS: Over a third of type-specific HPV infections in men remained persistent over a 24-month period. The median duration of HPV infection was longer in penile samples compared to seminal samples. As being increasing the attention of HPV vaccination as a potential preventive approach also for men, it is imperative to obtain additional insight on natural history of HPV infection in men, particularly as far as incidence and duration are concerned.


Subject(s)
Papillomaviridae/isolation & purification , Papillomavirus Infections/diagnosis , Penis/virology , Semen/virology , Specimen Handling/methods , Adolescent , Adult , Cohort Studies , Female , Genotype , Humans , Male , Middle Aged , Papillomaviridae/genetics , Papillomavirus Infections/etiology , Papillomavirus Infections/prevention & control , Polymerase Chain Reaction/methods , Urethra/virology , Young Adult
11.
Neurobiol Aging ; 6(4): 337-9, 1985.
Article in English | MEDLINE | ID: mdl-4088427

ABSTRACT

Acetylcholine release was investigated in cortical slices superfused with choline-enriched Krebs solution containing physostigmine. Slices were prepared from 3 and 24 month old rats treated with either Tris buffer or sonicated suspensions of phosphatidylserine and phosphatidylcholine in Tris buffer. Slices were electrically stimulated at frequencies of 1, 2 and 5 Hz for 5 min periods preceded and followed by rest periods. ACh content of the superfusate was quantified by bioassay. In the 24 month old rats treated with Tris buffer, acetylcholine release, at all frequencies tested, was approximately 50% lower than that in the 3 month old rats. On the contrary, no significant decrease in ACh release was found in the 24 month old rats treated for 30 days with phosphatidylserine (15 mg/kg IP). The same treatment did not increase acetylcholine release in 3 month old rats. Acetylcholine release in 24 month old rats receiving a single administration of phosphatidylserine (15 mg/kg IP) or phosphatidylcholine (15 mg/kg IP) for 30 days was as low as in the 24 month old rats receiving the Tris buffer only. It is proposed that the chronic phosphatidylserine treatment may reduce the age-induced decrease in acetylcholine release by acting on the stimulus-secretion coupling mechanism.


Subject(s)
Acetylcholine/metabolism , Aging , Cerebral Cortex/metabolism , Phosphatidylserines/pharmacology , Animals , Electric Stimulation , In Vitro Techniques , Male , Phosphatidylcholines/pharmacology , Rats , Rats, Inbred Strains , Stimulation, Chemical
12.
Neuroscience ; 66(4): 781-92, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7651609

ABSTRACT

The nucleus basalis of male Charles River Wistar rats was injected with 10 micrograms of the beta-amyloid peptides beta-(1-40) and beta-(25-35) and changes in the morphology of the lesioned area, the release of acetylcholine from the cortex, and in behavior were investigated. Injections of saline and a scrambled (25-35) peptide were used as controls. One week after lesioning, a Congo Red-positive deposit of aggregated material was found at the beta-peptides injection site, which lasted for about 21 days in the case of the beta-(25-35) peptide and at least two months for beta-(1-40). No deposit was detected after scrambled peptide injection. At one week post injection, an extensive glial reaction surrounded the injection site of all peptides and saline as well. Such a reaction was still present but rather attenuated after two months. A decrease in the number of cholinergic neurons was detected in the nucleus basalis after one week with all treatments except saline. After two months, a reduction in the number of choline acetyltransferase-immunopositive neurons was still detectable in the rats injected with beta-(1-40) but not in the beta-(25-35)-or scrambled-injected. The reduction in choline acetyltransferase immunoreactivity was closely paralleled by a decrease in basal acetylcholine release from the parietal cortex ipsilateral to the lesion. Disruption of object recognition was observed in the first weeks after beta-(25-35) peptide injection, whereas the beta-(1-40) peptide impaired the performance only two months after lesion. Rats with lesions induced by beta-peptides may be a useful animal model of amyloid deposition for investigation of the pathogenetic mechanisms leading to Alzheimer's disease.


Subject(s)
Amyloid beta-Peptides/pharmacology , Peptide Fragments/pharmacology , Substantia Innominata/drug effects , Acetylcholine/metabolism , Amyloid beta-Peptides/metabolism , Animals , Behavior, Animal/drug effects , Choline O-Acetyltransferase/drug effects , Choline O-Acetyltransferase/immunology , Immunohistochemistry , Male , Peptide Fragments/metabolism , Rats , Rats, Wistar , Sodium Chloride , Substantia Innominata/metabolism
13.
Neuroscience ; 87(2): 349-57, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9740397

ABSTRACT

The long-term effects of beta-amyloid peptide 1-40 injection into the rat forebrain were studied. Ten micrograms of pre-aggregated peptide were injected into the right nucleus basalis of male Wistar rats which were then killed four or six months later. Congo Red staining of histological sections showed that the peptide deposit was aggregated in a fibrillary form four months post-surgery, whereas at six months almost no trace of birefringency was detected at the deposit site, indicating a loss of fibril organization. This result was confirmed by electron microscopic analysis of the peptide deposits. The presence of the peptide at the injection site six months post-surgery was demonstrated by both Haematoxylin staining and beta-amyloid immunoreactivity. The number of choline acetyltransferase-immunoreactive neurons was reduced by 66% in the injected nucleus basalis four months after injection. A decrease in cortical acetylcholine release was also found at this time. Concomitantly with the loss of fibril conformation, a complete recovery of choline acetyltransferase immunoreactivity in the nucleus basalis and of acetylcholine release in the cortex was observed at six months. These data provide in vivo evidence that beta-amyloid neurotoxicity is related to the fibrillary conformation of the peptide aggregates, thus confirming previous in vitro studies.


Subject(s)
Amyloid beta-Peptides/toxicity , Brain/cytology , Peptide Fragments/toxicity , Acetylcholine/metabolism , Amyloid beta-Peptides/administration & dosage , Animals , Basal Ganglia/cytology , Basal Ganglia/drug effects , Brain/drug effects , Cell Aggregation/drug effects , Choline O-Acetyltransferase/metabolism , Immunohistochemistry , Male , Microscopy, Electron , Peptide Fragments/administration & dosage , Rats , Rats, Wistar
14.
Neuroscience ; 91(3): 831-42, 1999.
Article in English | MEDLINE | ID: mdl-10391466

ABSTRACT

Interleukin-1beta (10 U) was injected into the nucleus basalis of adult male Wistar rats. The inflammation-induced changes in glial cell morphology and expression of inducible nitric oxide synthase in the injected area, the release of acetylcholine, GABA and glutamate from the ipsilateral cortex, the production of nitrite levels in the injected area and ipsilateral cortex, and changes in motor activity were investigated. Saline-injected rats were used as control. Interleukin-1beta induced an activation of both microglia and astrocytes which was already evident 24 h after injection. Seven days after injection, many reactive microglial cells and astrocytes were seen in the injected area and in other brain regions of the same hemisphere. Microglia reaction, but not astrocyte activation, disappeared 30 days post-injection. Seven days after interleukin-1beta injection, many cells immunopositive for inducible nitric oxide synthase were found surrounding the injection site. Inducible nitric oxide synthase-positive cells were identified, by double staining immunohistochemistry, in the reactive microglial cells and, by electron microscope examination, in the perineuronal subpopulation of resident activated microglia. Microdialysis investigations revealed a transient increase in reactive nitrogen intermediates (at seven days post-injection), a delayed (at 30 days post-injection) increase in GABA and glutamate release, and no changes in acetylcholine release in the ipsilateral cortex in interleukin-1beta, but not saline, injected rats. Inhibition of inducible nitric oxide synthase expression by N(G)-nitro-L-arginine methyl ester administration prevented the increase in nitrogen intermediates and GABA release, but not in glutamate release. Our findings suggest that an inflammatory reaction of the basal forebrain facilitates GABA release through the production of nitric oxide.


Subject(s)
Cerebral Cortex/metabolism , Glutamic Acid/metabolism , Interleukin-1/pharmacology , Nitric Oxide/biosynthesis , Prosencephalon/physiology , gamma-Aminobutyric Acid/metabolism , Acetylcholine/metabolism , Alzheimer Disease/metabolism , Animals , Extracellular Space/metabolism , Immunohistochemistry , Male , Motor Activity/drug effects , Neuroglia/diagnostic imaging , Neuroglia/physiology , Prosencephalon/cytology , Prosencephalon/diagnostic imaging , Prosencephalon/drug effects , Rats , Rats, Wistar , Ultrasonography
15.
Br J Pharmacol ; 124(6): 1286-92, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9720802

ABSTRACT

1. Bradykinin (BK) contributes to the inflammatory response inducing vasodilation of postcapillary venules and has been demonstrated to induce neovascular growth in subcutaneous rat sponges. 2. In this study the ability of BK to stimulate cell growth and migration in cultured endothelium from coronary postcapillary venules (CVEC) has been investigated. 3. [3H]-thymidine incorporation in subconfluent and synchronised CVEC was used to monitor DNA synthesis over 24 h. BK promoted a concentration-dependent increase of DNA synthesis with maximal activity at 100 nM. At this concentration BK also induced 18 fold accumulation of c-Fos protein immunoreactivity in the nucleus within 1 h from peptide exposure. 4. The total number of cells recovered after 48 h exposure to BK was increased in a concentration-dependent manner. Maximal effect was produced by 100 nM concentration of the peptide which produced 50% increase in cell number. The selective B1 receptor agonist Des-Arg9-BK mimicked the proliferative effect of BK, while the B2 receptor agonist kallidin was devoid of any activity. The proliferation induced by BK was abolished in a concentration-dependent manner by the addition of the B1 selective antagonist Des-Arg9-Leu8-BK, while the selective B2 receptor antagonist HOE140 did not modify BK-induced growth. 5. DNA synthesis and growth promoted by a threshold concentration of fibroblast growth factor-2 (FGF-2) (0.25 nM) were potentiated by increasing concentrations of BK and Des-Arg9-BK. 6. Endothelial cell migration assessed by the Boyden Chamber procedure was not promoted by BK or the selective B1 and B2 receptor agonists. 7. These data are the first demonstration that BK promotes growth of endothelial cells from postcapillary venules. The mitogenic activity of BK involves c-Fos expression and potentiates the growth promoting effect of FGF-2. Only the B1 receptor appears to be responsible for the proliferation induced by BK and suggests that this type of receptor might be implicated in favouring angiogenesis of coronary venules.


Subject(s)
Bradykinin/physiology , Endothelium, Vascular/drug effects , Fibroblast Growth Factor 2/pharmacology , Receptors, Bradykinin/physiology , Venules/drug effects , Animals , Cattle , Cell Movement/drug effects , Cells, Cultured , DNA Replication/drug effects , Drug Synergism , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Receptor, Bradykinin B1 , Receptors, Bradykinin/agonists , Receptors, Bradykinin/classification , Urokinase-Type Plasminogen Activator/metabolism , Venules/cytology , Venules/metabolism
16.
Br J Pharmacol ; 134(3): 596-602, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11588114

ABSTRACT

1. We investigated the effect of the NO-donor S-nitroso-N-acetyl-DL-penicillamine (SNAP) on cardiomyocytes isolated from control normotensive Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats. 2. Ventricular cardiomyocytes were isolated from SHR and WKY hearts and imaging analysis of fura-2-loaded cells was performed in order to evaluate calcium transient in electrical field paced (0.5 Hz) cells. 3. In WKY cardiomyocytes, 1 - 200 microM SNAP dose-dependently increased cyclic GMP content. In basal conditions, cyclic GMP content of SHR cardiomyocytes was significantly higher than in WKY, but SNAP failed to further increase cyclic GMP over the basal level. 4. In control conditions, the Delta F/F and decay time of the calcium transient were similar in both strains. In WKY cardiomyocytes, SNAP (1 - 100 microM) reduced the decay time. In SHR cardiomyocytes, SNAP was ineffective. Dibutyryl cyclic GMP (10(-6) - 10(-8) M), a membrane permeable cyclic GMP analogue, behaved similarly to SNAP. 5. In WKY and SHR cardiomyocytes, 10(-8) M isoprenaline similarly increased Delta F/F and decreased the decay time. SNAP and dibutyryl cyclic GMP prevented the effect of isoprenaline in WKY, whereas both molecules were ineffective in SHR cardiomyocytes. In WKY, SNAP effects were blocked by pretreating cells with the cGK inhibitor KT-5823. 6. Western blotting analysis of cGK type I showed that the enzyme was expressed in WKY isolated cardiomyocytes, but absent in four out of five SHR preparations. 7. We concluded that the low expression of cGKI may determine the lack of NO/cyclic GMP-dependent regulation on calcium transient in SHR cardiomyocytes. This alteration may contribute to the development of heart hypertrophy in hypertensive status.


Subject(s)
Cyclic GMP/physiology , Myocardium/metabolism , Animals , Cells, Cultured , Cyclic GMP/biosynthesis , Dibutyryl Cyclic GMP/pharmacology , Enzyme Inhibitors/pharmacology , Heart Ventricles/cytology , Heart Ventricles/drug effects , Heart Ventricles/metabolism , Myocardium/cytology , Nitric Oxide/biosynthesis , Rats , Rats, Inbred SHR , Rats, Inbred WKY , S-Nitroso-N-Acetylpenicillamine/pharmacology , Species Specificity
17.
Br J Pharmacol ; 130(7): 1468-76, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10928946

ABSTRACT

While the expression and/or activity of endothelial nitric oxide synthase (eNOS) has been characterized in spontaneously hypertensive (SHR) and normotensive Wistar Kyoto rat (WKY) hearts, in coronary endothelial cells (ECs) from both strains, the effect of NO on intracellular calcium concentration ([Ca(2+)](i)) is still unknown. Coronary microvascular ECs were isolated from SHR and WKY and characterized. Immunocytochemistry and Western blot analysis showed that eNOS was similarly expressed in ECs from both strains. Measuring [Ca(2+)](i) by imaging analysis of fura-2-loaded cells, we demonstrated that alpha-thrombin (3-180 U l(-1)) induced a superimposable dose-dependent calcium transient in ECs from both strains. In WKY ECs, S-nitroso-N-acetyl-DL-penicillamine (SNAP) dose-dependently (10 - 100 microM) and 0.1 microM atrial natriuretic factor (ANF) reduced the maximum and the decay time of alpha-thrombin-induced calcium transient. The inhibitory effects of SNAP and ANF were prevented by blocking cyclic GMP-dependent protein kinase. Non selective eNOS inhibitors prolonged the decay time of alpha-thrombin-induced calcium transient, while the selective inducible NOS inhibitor 1400 W was ineffective. SNAP (100 microM) and 0.1 microM ANF increased cyclic GMP content up to 22.9 and 42.3 fold respectively. In SHR ECs, alpha-thrombin-induced calcium transient was not modified by SNAP, ANF or eNOS inhibition. SNAP (100 microM) and 0.1 microM ANF increased cyclic GMP content up to 9. 3 and 51 fold respectively. In WKY ECs, SNAP dose-dependently (10 - 100 microM) reduced also bradykinin-induced calcium transient, while in SHR ECs was ineffective. We concluded that in SHR ECs, the cyclic GMP-dependent regulation of calcium transient is lost.


Subject(s)
Calcium/metabolism , Cyclic GMP/metabolism , Drosophila Proteins , Endothelium, Vascular/metabolism , Hypertension/metabolism , Nitric Oxide/metabolism , Penicillamine/analogs & derivatives , RNA-Binding Proteins , Animals , Atrial Natriuretic Factor/metabolism , Bradykinin/metabolism , Endothelium, Vascular/drug effects , Endothelium, Vascular/enzymology , Endothelium, Vascular/immunology , Insect Proteins/metabolism , Myocardium/pathology , Nitric Oxide Donors/pharmacology , Penicillamine/pharmacology , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Thrombin/metabolism
18.
Exp Gerontol ; 23(3): 175-81, 1988.
Article in English | MEDLINE | ID: mdl-3203718

ABSTRACT

The effect of adenosine, N-ethylcarboxamide adenosine (NECA), and caffeine on acetylcholine (ACh) release was investigated in cortical slices prepared from 3 and 22-24-month-old rats. The slices were perfused with Krebs solution and electrically stimulated at 0.2, 1, and 5 Hz stimulation frequency. In old rats, ACh released by stimulation at 1 and 5 Hz was about half as large as in adult rats. In 22-24-month-old rats, the potency of adenosine was strongly reduced, and a similar significant inhibition of ACh release was obtained with concentrations of 1 microM adenosine in adult and 300 microM in old rats. Conversely, NECA, which has no effect on ACh release in adult rats, brought about a 40% decrease in old rats. Caffeine at 50 microM concentration enhanced, and at 500 microM inhibited, the evoked ACh release in adult rats, but was inactive in old rats. The possibility is envisaged that aging may modify purinergic modulation of ACh release by inducing conformational changes in purinergic receptors or changing adenosine metabolism.


Subject(s)
Acetylcholine/metabolism , Adenosine/pharmacology , Parietal Lobe/growth & development , Adenosine/analogs & derivatives , Adenosine-5'-(N-ethylcarboxamide) , Aging , Animals , Caffeine/pharmacology , Dose-Response Relationship, Drug , Electric Stimulation , In Vitro Techniques , Male , Parietal Lobe/drug effects , Parietal Lobe/physiology , Rats , Rats, Inbred Strains
19.
Cancer Genet Cytogenet ; 74(2): 144-6, 1994 Jun.
Article in English | MEDLINE | ID: mdl-8019959

ABSTRACT

Trisomy 8 is a relatively common finding in acute nonlymphoblastic leukemia (ANLL). In childhood acute lymphoblastic leukemia (ALL) it apparently is much more rare. Although Human Gene Mapping 11 included trisomy 8 as a marker for a subgroup of ALL, morphologic and immunologic characteristics of this entity have not been defined. We describe a case of early T-cell ALL (T-ALL) in a pediatric patient in whom this abnormality was the sole chromosome aberration. In situ hybridization with a chromosome 8-specific alpha-satellite DNA probe was performed. Our data are discussed and compared with pertinent literature.


Subject(s)
Chromosomes, Human, Pair 8 , Leukemia-Lymphoma, Adult T-Cell/genetics , Trisomy , Child, Preschool , Female , Humans , Immunophenotyping , In Situ Hybridization, Fluorescence
20.
Brain Res ; 853(1): 136-41, 2000 Jan 17.
Article in English | MEDLINE | ID: mdl-10627317

ABSTRACT

The induction of the c-fos gene in the rat brain by NGF was studied in a model of acute cholinergic hypofunction, i.e., the lesion of the nucleus basalis magnocellularis (NBM) with quisqualic acid. Choline acetyltransferase and Fos immunoreactivity (IR) in the NBM were analyzed at different times after the excitotoxic lesion. NGF treatment induced a potentiation of Fos expression 4 and 24 h after lesion. The possibility is discussed that c-fos induction is one of the early mechanisms of the neuroprotective action of NGF.


Subject(s)
Basal Nucleus of Meynert/drug effects , Nerve Growth Factor/pharmacology , Proto-Oncogene Proteins c-fos/biosynthesis , Animals , Basal Nucleus of Meynert/enzymology , Cerebral Cortex/enzymology , Choline O-Acetyltransferase/biosynthesis , Drug Synergism , Hypothalamus/enzymology , Immunohistochemistry , Injections, Intraventricular , Male , Nerve Growth Factor/administration & dosage , Neurons/drug effects , Neurons/enzymology , Proto-Oncogene Proteins c-fos/drug effects , Quisqualic Acid/pharmacology , Rats , Rats, Wistar , Thalamus/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL